What changed from existing technology?
This study looked at how a protein called NUPR1 works in different types of cancer and found it is involved in how cancer cells grow and interact with the surrounding tissue.
This study is the first to comprehensively analyze NUPR1 across multiple cancer types using both bulk and single-cell RNA sequencing data.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 0
- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
- 장기·실사용 검증 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Validation stage
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
The findings suggest NUPR1 could be a potential target for cancer therapy, but further research is needed to confirm its clinical utility.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.